It was shown that while anti‐PD‐1 therapy did not increase γδ T‐cell cytotoxicity, anti‐PD‐L1 therapy did increase the cytotoxicity of γδ T cells against cancer cells that had been pre‐treated with ZOL.63 This evidence concerns the gene PDCD1 and cancer.